Perceptions Associated with Noncompliance to Community-Wide Mass Drug Administration for Soil-Transmitted Helminths

Am J Trop Med Hyg. 2023 Aug 21;109(4):830-834. doi: 10.4269/ajtmh.23-0176. Print 2023 Oct 4.

Abstract

Mass drug administration (MDA) is a key strategy for the control of soil-transmitted helminths (STHs). Within MDA programs, poor and non-random compliance threaten successful control of STHs. A case-control study was conducted comparing perceptions among non-compliant participants with compliant participants during a community-wide MDA (cMDA) with albendazole in southern India. Common reasons cited for non-compliance were that the individual was not infected with STH (97.4%), the perception that he/she was healthy (91%), fear of side-effects (12.8%), and dislike of consuming tablets (10.3%). Noncompliance was associated with poor awareness of intestinal worms (odds ratio [OR]: 9.63, 95% CI: 2.11-43.84), the perception that cMDA was only required for those with worms (OR: 2.14, 95% CI: 1.06-4.36), and the perception that the drug is not safe during pregnancy (OR: 2.19, 95% CI: 1.18-4.07) or when on concomitant medications (OR: 3.14, 95% CI: 1.38-7.15). Understanding of perceptions driving noncompliance can provide valuable insights to optimize participation during MDA for STHs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anthelmintics* / therapeutic use
  • Case-Control Studies
  • Female
  • Helminthiasis* / drug therapy
  • Helminthiasis* / parasitology
  • Helminthiasis* / prevention & control
  • Helminths*
  • Humans
  • Mass Drug Administration
  • Prevalence
  • Soil / parasitology

Substances

  • 4-((2-chloroethyl)(2-mesyloxyethyl)amino)benzoylglutamic acid
  • Soil
  • Anthelmintics